Ex-Metacrine chief Preston Klassen recharges at microRNA biotech; Allogene begins search for a CFO

Preston Klassen

Preston Klassen has mapped out his next destination as president and R&D chief of microRNA developer Regulus Therapeutics. Klassen was the CEO of Metacrine, a biotech co-founded and chaired by Rich Heyman that was ensnarled in toxicity issues…